How CDC Is making COVID-19 vaccine recommendations

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated Mar. 3, 2021
  
  When the Food and Drug Administration (FDA) authorizes or approves a COVID-19 vaccine, the Advisory Committee on Immunization Practices (ACIP) will quickly hold a public meeting to review all available data about that vaccine (sign up to receive email updates whenever ACIP’s Meeting Information is updated). Before making recommendations, ACIP reviews all available clinical trial information, including descriptions of:
  
  • Who is receiving each vaccine (age, race, ethnicity, underlying medical conditions)
  
  • How different groups respond to the vaccine
  
  • Side effects of each vaccine
  
  From these data, ACIP will then vote on whether to recommend the vaccine. ACIP also votes on recommendations for who should be offered COVID-19 vaccine first when supplies are limited.
  
  
• Subjects:
  Coronavirus Infections/prevention & Control COVID-19 Vaccines Pandemics Patient Safety Vaccination Viral Vaccines
• Document Type:
  Webpage
• Name as Subject:
  United States. Advisory Committee on Immunization Practices. Adult Immunization Work Group.
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:176d2af4c086ae116faa8010fc1226effdf7c6088e28789a2691f8ab8087e82c
• Download URL:
  https://stacks.cdc.gov/view/cdc/103694/cdc_103694_DS1.pdf
• File Type:
  [PDF - 114.88 KB ]